Ipsilateral Upper-Limb Lymphedema After COVID-19 Vaccine Booster.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 36302077.
- Also identified by DOI 10.1097/RLU.0000000000004470 and PMC identifier 9907355.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent data suggest that protective immunity from COVID-19 vaccine may wane after a period, with booster doses becoming increasingly deployed in many countries. An 84-year-old woman presents with a 6-month history of left upper-limb swelling; the only history of note was an intramuscular Pfizer-BioNTech mRNA vaccine booster in the ipsilateral deltoid just 1 week before the onset of the swelling. Upper-extremity lymphoscintigraphy after the administration of 99m Tc-nanocolloid into the interstitial space of the hands showed left upper-limb lymphatic dysfunction.
Medical subject headings
- COVID-19
- COVID-19 Vaccines
- Lymphedema